Assignee
SCANCELL LTD
GB9 patents
Top patents by PatentIndex Score
US7267821B2Sep 11, 2007
Binding member which binds to both Lewisy and Lewisb haptens, and its use for treating cancer
SCANCELL LTD9 citations70
US10233220B2Mar 19, 2019
Anti-tumour response to modified self-epitopes
SCANCELL LTD4 citations67
US12552876B2Feb 17, 2026
Anti-fucosyl-GM1 antibodies
SCANCELL LTD0 citations60
US12258377B2Mar 25, 2025
Anti-tumour response to modified self-epitopes
SCANCELL LTD0 citations56
US12458688B2Nov 4, 2025
Epitopes
SCANCELL LTD0 citations55
US11382985B2Jul 12, 2022
Anti-tumour immune responses to modified self-epitopes
SCANCELL LTD0 citations54
US10695438B2Jun 30, 2020
Anti-tumour immune responses to modified self-epitopes
SCANCELL LTD1 citations54
US12595313B2Apr 7, 2026
Modified Fc-regions to enhance functional affinity of antibodies and antigen binding fragments thereof
SCANCELL LTD0 citations52
US6258528B1Jul 10, 2001
Signal amplification method
SCANCELL LTD1 citations51